Full Year 2023 Investor Presentation
24.
Investor presentation
Full year 2023
Sales growth of 36%, driven by both NAO and IO with 54% and
16% sales growth respectively
Total in
DKK billion
Historic and reported sales by geography
Reported sales and growth breakdown
for the full year 2023
Novo NordiskⓇ
111.8
177.0
232.3
Regions
Sales
(mDKK)
Share of
Growth
growth
9%
14%
12%
10%
International Operations
95,632
16%
22%
7%
9%
EMEA
50,867
17%
12%
22%
30%
25%
Region China
16,687
11%
3%
ROW
28,078
15%
7%
59%
North America Operations
136,629
54%
78%
51%
52%
Hereof USA
127,534
55%
73%
Total sales
232,261
36%
100%
2018
North America
2022
2023
EMEA
Region China
ROW
IO: International Operations; NAO: North American Operations; EMEA: Europe, Middle East, and Africa; Row: Rest of World; Region China covers mainland China, Hong Kong and Taiwan
Note: Numbers may not add up to 100% due to rounding; Growth at Constant exchange rates; Sales numbers are reported in Danish kroner
Source: Quarterly company announcementView entire presentation